Tamoxifen and breast cancer: hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, second session, special hearing
U.S. G.P.O., Jan 1, 1998 - Medical - 50 pages
5 pages matching first-degree relatives in this book
Results 1-3 of 5
What people are saying - Write a review
We haven't found any reviews in the usual places.
BCPT participants Bernard Fisher Biographical Sketch biopsy blood clots Bowel Project NSABP Breast and Bowel Breast Cancer Prevention breast cancer risk Cancer Information Service Cancer Prevention Trial Chairman clinical trials commitment committee conduct daughter deep vein thrombosis developing breast cancer diagnosed Director disease drug endometrial cancer ERSMAC estrogen first-degree relatives funding Harold Varmus hormone important incidence of breast increased risk invasive breast cancer Klausner LAUCH FAIRCLOTH lobular carcinoma mother National Cancer Institute National Surgical Adjuvant Nolvadex Norman Wolmark NSABP clinical trials oncology Participant Advisory Board percent physicians pills placebo group prevent breast cancer raloxifene reduce risk of breast risk of developing risks and benefits Senator Faircloth Senator Specter side effects subcommittee Surgical Adjuvant Breast take tamoxifen tamoxifen group versus tamoxifen therapy Thank took tamoxifen treatment uterine cancer uterus Varmus woman women at increased Zeneca